# Corpay, Inc.: financial statements, quarterly

CPAY · NYSE · CIK 1175454 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cpay.md) · [Financials](/companies/cpay/financials.md) · [Filings](/companies/cpay/filings.md) · [Insiders](/companies/cpay/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cpay/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [971](/filings/0001628280-24-046515.md) | [937 d](/filings/0001175454-26-000018.md) | [935](/filings/0001628280-25-024747.md) | [976](/filings/0001175454-25-000018.md) | [1,029](/filings/0001175454-25-000029.md) | [1,034 d](/filings/0001175454-26-000018.md) | [1,006](/filings/0001175454-26-000032.md) | [1,102](/filings/0001175454-26-000050.md) | [1,172](/filings/0001175454-25-000029.md) | [1,248 d](/filings/0001175454-26-000018.md) | [1,261](/filings/0001175454-26-000032.md) | [1,339](/filings/0001175454-26-000050.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [445](/filings/0001628280-24-046515.md) | [424 d](/filings/0001175454-26-000018.md) | [397](/filings/0001628280-25-024747.md) | [433](/filings/0001175454-25-000018.md) | [468](/filings/0001175454-25-000029.md) | [488 d](/filings/0001175454-26-000018.md) | [427](/filings/0001175454-26-000032.md) | [479](/filings/0001175454-26-000050.md) | [523](/filings/0001175454-25-000029.md) | [564 d](/filings/0001175454-26-000018.md) | [636](/filings/0001175454-26-000032.md) | [472](/filings/0001175454-26-000050.md) |
| Interest expense | $m | [88.3](/filings/0001628280-24-046515.md) | [92.0 d](/filings/0001175454-26-000018.md) | [89.1](/filings/0001628280-25-024747.md) | [94.7](/filings/0001175454-25-000018.md) | [104](/filings/0001175454-25-000029.md) | [94.8 d](/filings/0001175454-26-000018.md) | [93.9](/filings/0001175454-26-000032.md) | [96.9](/filings/0001175454-26-000050.md) | [100](/filings/0001175454-25-000029.md) | [113 d](/filings/0001175454-26-000018.md) | [110](/filings/0001175454-26-000032.md) | [115](/filings/0001175454-26-000050.md) |
| Income tax | $m | [98.6](/filings/0001628280-24-046515.md) | [77.6 d](/filings/0001175454-26-000018.md) | [75.5](/filings/0001628280-25-024747.md) | [82.5](/filings/0001175454-25-000018.md) | [82.0](/filings/0001175454-25-000029.md) | [141 d](/filings/0001175454-26-000018.md) | [83.6](/filings/0001175454-26-000032.md) | [109](/filings/0001175454-26-000050.md) | [143](/filings/0001175454-25-000029.md) | [134 d](/filings/0001175454-26-000018.md) | [151](/filings/0001175454-26-000032.md) | [92.9](/filings/0001175454-26-000050.md) |
| Net income | $m | [271](/filings/0001628280-24-046515.md) | [256 d](/filings/0001175454-26-000018.md) | [230](/filings/0001628280-25-024747.md) | [252](/filings/0001175454-25-000018.md) | [276](/filings/0001175454-25-000029.md) | [246 d](/filings/0001175454-26-000018.md) | [243](/filings/0001175454-26-000032.md) | [284](/filings/0001175454-26-000050.md) | [278](/filings/0001175454-25-000029.md) | [264 d](/filings/0001175454-26-000018.md) | [350](/filings/0001175454-26-000032.md) | [248](/filings/0001175454-26-000050.md) |
| Diluted EPS | $ per share | [3.64](/filings/0001628280-24-046515.md) | not reported | [3.12](/filings/0001628280-25-024747.md) | [3.52](/filings/0001175454-25-000018.md) | [3.90](/filings/0001175454-25-000029.md) | not reported | [3.40](/filings/0001175454-26-000032.md) | [3.98](/filings/0001175454-26-000050.md) | [3.91](/filings/0001175454-25-000029.md) | not reported | [5.07](/filings/0001175454-26-000032.md) | [3.70](/filings/0001175454-26-000050.md) |
| Basic EPS | $ per share | [3.71](/filings/0001628280-24-046515.md) | not reported | [3.20](/filings/0001628280-25-024747.md) | [3.59](/filings/0001175454-25-000018.md) | [3.98](/filings/0001175454-25-000029.md) | not reported | [3.46](/filings/0001175454-26-000032.md) | [4.03](/filings/0001175454-26-000050.md) | [3.95](/filings/0001175454-25-000029.md) | not reported | [5.14](/filings/0001175454-26-000032.md) | [3.75](/filings/0001175454-26-000050.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: not reported
- Gross profit: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [1.1](/filings/0001628280-24-046515.md) | [1.4](/filings/0001175454-26-000018.md) | [1.3](/filings/0001628280-25-024747.md) | [1.4](/filings/0001175454-25-000018.md) | [1.3](/filings/0001175454-25-000029.md) | [1.6](/filings/0001175454-26-000050.md) | [1.6](/filings/0001628280-25-024747.md) | [2.2](/filings/0001175454-26-000050.md) | [2.0](/filings/0001175454-25-000029.md) | [2.4](/filings/0001175454-26-000050.md) | [2.5](/filings/0001175454-26-000032.md) | [3.2](/filings/0001175454-26-000050.md) |
| Current assets | $bn | [7.3](/filings/0001628280-24-008060.md) | [7.1](/filings/0001628280-25-008746.md) | [7.4](/filings/0001628280-24-021986.md) | [8.0](/filings/0001628280-24-036429.md) | [8.8](/filings/0001628280-24-046515.md) | [8.7](/filings/0001175454-26-000018.md) | [9.1](/filings/0001628280-25-024747.md) | [10.8](/filings/0001175454-25-000018.md) | [10.1](/filings/0001175454-25-000029.md) | [14.0](/filings/0001175454-26-000050.md) | [14.6](/filings/0001175454-26-000032.md) | [16.5](/filings/0001175454-26-000050.md) |
| Total assets | $bn | [15.7](/filings/0001628280-24-008060.md) | [15.5](/filings/0001628280-25-008746.md) | [15.8](/filings/0001628280-24-021986.md) | [16.2](/filings/0001628280-24-036429.md) | [17.6](/filings/0001628280-24-046515.md) | [18.0](/filings/0001175454-26-000018.md) | [18.5](/filings/0001628280-25-024747.md) | [20.4](/filings/0001175454-25-000018.md) | [19.7](/filings/0001175454-25-000029.md) | [26.4](/filings/0001175454-26-000050.md) | [26.7](/filings/0001175454-26-000032.md) | [28.2](/filings/0001175454-26-000050.md) |
| Current liabilities | $bn | [7.1](/filings/0001628280-24-008060.md) | [6.8](/filings/0001628280-25-008746.md) | [7.0](/filings/0001628280-24-021986.md) | [7.8](/filings/0001628280-24-036429.md) | [8.3](/filings/0001628280-24-046515.md) | [8.7](/filings/0001175454-26-000018.md) | [8.2](/filings/0001628280-25-024747.md) | [9.6](/filings/0001175454-25-000018.md) | [8.9](/filings/0001175454-25-000029.md) | [14.3](/filings/0001175454-26-000050.md) | [15.0](/filings/0001175454-26-000032.md) | [17.0](/filings/0001175454-26-000050.md) |
| Long-term debt | $bn | not reported | [6.7](/filings/0001628280-25-008746.md) | not reported | not reported | not reported | [8.0](/filings/0001175454-26-000018.md) | [8.2](/filings/0001628280-25-024747.md) | [8.1](/filings/0001175454-25-000018.md) | [8.1](/filings/0001175454-25-000029.md) | [10.0](/filings/0001175454-26-000050.md) | [10.4](/filings/0001175454-26-000032.md) | [10.6](/filings/0001175454-26-000050.md) |
| Current portion of debt | $bn | [2.3](/filings/0001628280-23-038098.md) | [2.1](/filings/0001628280-25-008746.md) | [1.9](/filings/0001628280-24-021986.md) | [2.5](/filings/0001628280-24-036429.md) | [2.5](/filings/0001628280-24-046515.md) | [2.8](/filings/0001175454-26-000018.md) | [2.3](/filings/0001628280-25-024747.md) | [2.2](/filings/0001175454-25-000018.md) | [2.3](/filings/0001175454-25-000029.md) | [3.3](/filings/0001175454-26-000050.md) | [3.8](/filings/0001175454-26-000032.md) | [4.5](/filings/0001175454-26-000050.md) |
| Shareholders' equity | $bn | [3.1](/filings/0001628280-24-046515.md) | [3.3](/filings/0001628280-25-008746.md) | [3.3](/filings/0001628280-24-021986.md) | [2.8](/filings/0001628280-24-036429.md) | [3.1](/filings/0001628280-24-046515.md) | [3.1](/filings/0001175454-26-000018.md) | [3.5](/filings/0001628280-25-024747.md) | [3.9](/filings/0001175454-25-000018.md) | [4.1](/filings/0001175454-25-000029.md) | [3.9](/filings/0001175454-26-000050.md) | [3.5](/filings/0001175454-26-000032.md) | [3.5](/filings/0001175454-26-000050.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [286 d](/filings/0001628280-24-046515.md) | [717 d](/filings/0001175454-26-000018.md) | [350](/filings/0001628280-25-024747.md) | [541 d](/filings/0001175454-25-000018.md) | [401 d](/filings/0001175454-25-000029.md) | [649 d](/filings/0001175454-26-000018.md) | [(74.2)](/filings/0001175454-26-000032.md) | [1,140 d](/filings/0001175454-26-000050.md) | [(379) d](/filings/0001175454-25-000029.md) | [813 d](/filings/0001175454-26-000018.md) | [(56.6)](/filings/0001175454-26-000032.md) | [1,470 d](/filings/0001175454-26-000050.md) |
| Capital expenditure | $m | [38.2 d](/filings/0001628280-24-046515.md) | [36.7 d](/filings/0001175454-26-000018.md) | [41.2](/filings/0001628280-25-024747.md) | [44.1 d](/filings/0001175454-25-000018.md) | [45.8 d](/filings/0001175454-25-000029.md) | [44.1 d](/filings/0001175454-26-000018.md) | [44.8](/filings/0001175454-26-000032.md) | [52.6 d](/filings/0001175454-26-000050.md) | [50.9 d](/filings/0001175454-25-000029.md) | [52.4 d](/filings/0001175454-26-000018.md) | [51.1](/filings/0001175454-26-000032.md) | [54.4 d](/filings/0001175454-26-000050.md) |
| Share repurchases | $m | [535 d](/filings/0001628280-24-046515.md) | [140 d](/filings/0001175454-26-000018.md) | [289](/filings/0001628280-25-024747.md) | [658 d](/filings/0001175454-25-000018.md) | [92.2 d](/filings/0001175454-25-000029.md) | [249 d](/filings/0001175454-26-000018.md) | [58.7](/filings/0001175454-26-000032.md) | [32.2 d](/filings/0001175454-26-000050.md) | [192 d](/filings/0001175454-25-000029.md) | [500 d](/filings/0001175454-26-000018.md) | [786](/filings/0001175454-26-000032.md) | [327 d](/filings/0001175454-26-000050.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [75.6](/filings/0001628280-23-038098.md) | [74.5](/filings/0001628280-24-021986.md) | [75.0](/filings/0001628280-24-036429.md) | [74.6](/filings/0001628280-24-046515.md) | [73.5](/filings/0001628280-25-024747.md) | [71.5](/filings/0001175454-25-000018.md) | [70.9](/filings/0001175454-25-000029.md) | [71.6](/filings/0001175454-26-000032.md) | [71.4](/filings/0001175454-26-000050.md) | [71.1](/filings/0001175454-25-000029.md) | [68.4](/filings/0001175454-26-000032.md) | [66.3](/filings/0001175454-26-000050.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 65,659,599 at 2026-07-31, from the cover of the [10-Q filed 2026-08-10](/filings/0001175454-26-000050.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.